The role of drug and disease registries in rheumatic disease epidemiology.
about
Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databasesUse of data from multiple registries in studying biologic discontinuation: challenges and opportunitiesUsing genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesGreater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registryThe importance of rheumatology biologic registries in Latin America.
P2860
The role of drug and disease registries in rheumatic disease epidemiology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of drug and disease registries in rheumatic disease epidemiology.
@en
The role of drug and disease registries in rheumatic disease epidemiology.
@nl
type
label
The role of drug and disease registries in rheumatic disease epidemiology.
@en
The role of drug and disease registries in rheumatic disease epidemiology.
@nl
prefLabel
The role of drug and disease registries in rheumatic disease epidemiology.
@en
The role of drug and disease registries in rheumatic disease epidemiology.
@nl
P2093
P1476
The role of drug and disease registries in rheumatic disease epidemiology.
@en
P2093
Allan Gibofsky
Jeffrey D Greenberg
Joel M Kremer
P304
P356
10.1097/BOR.0B013E3282F50EB1
P577
2008-03-01T00:00:00Z